Newly diagnosed MYC/BCL2 double-expressor DLBCL

Clinical trials for Newly diagnosed MYC/BCL2 double-expressor DLBCL explained in plain language.

Never miss a new study

Get alerted when new Newly diagnosed MYC/BCL2 double-expressor DLBCL trials appear

Sign up with your email to follow new studies for Newly diagnosed MYC/BCL2 double-expressor DLBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Chemo-Free start shows promise for High-Risk lymphoma in older adults

Disease control Ongoing

This study tests a three-step treatment for elderly patients (ages 60-80) with a high-risk type of lymphoma called double-expressor DLBCL. First, patients receive a chemotherapy-free drug combination. Depending on how well the cancer responds, they then get standard chemotherapy …

Matched conditions: NEWLY DIAGNOSED MYC/BCL2 DOUBLE-EXPRESSOR DLBCL

Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

Newly diagnosed MYC/BCL2 double-expressor DLBCL

Get alerted when new Newly diagnosed MYC/BCL2 double-expressor DLBCL trials appear

Chemo-Free start shows promise for High-Risk lymphoma in older adults